Skip to main content
SpringerLink
Log in
Book cover

Vaccine Design pp 229–248Cite as

Adjuvant Properties of Aluminum and Calcium Compounds

  • Chapter

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 6))

Abstract

Aluminum compounds, including aluminum phosphate (AIPO4), aluminum hydroxide [Al(OH)3], and alum-precipitated vaccines (historically referred to as protein aluminate), are currently widely used with human vaccines. These adjuvants have often been referred to as “alum” in the literature. Alum, which chemically is potassium aluminum sulfate [KA1(SO4)2.12H2O], has not been used as an adjuvant as such. Rather, it was used to partially purify protein antigens, mainly tetanus toxoid (TT) and diphtheria toxoid (DT) by precipitating them in the presence of anions including phosphate and bicarbonate ions resulting in a mixture of compounds, mainly aluminum phosphate and aluminum hydroxide (Holt, 1950; Aprile and Wardlaw, 1966). The amounts of aluminum phosphate and aluminum hydroxide in the mixture depended on the amount and nature of anions present in the reaction mixture and adjustment of pH of the final product with sodium hydroxide (Relyveld, 1986; Nicklas, 1992). Although alum-precipitated TT and DT had been used for human immunization for many years, their use has declined considerably because of variations in production of alum-precipitated toxoids (van Ramshorst, 1949; Holt, 1950; Aprile and Wardlaw, 1966; Gupta et al., 1993). Referring to all aluminum adjuvants as “alum” is misleading because aluminum hydroxide and aluminum phosphate have different physical characteristics (see Chapter 9) and differ in their adjuvant properties.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ad Hoc Group for the Study of Pertussis Vaccines, 1988, Placebo-controlled trial of two acellular pertussis vaccines in Sweden: Protective efficacy and adverse events, Lancet 1:955–960.

    Google Scholar 

  • Ahuja, S., Sharma, S. B., Gupta, R. K., Maheshwari, S. C., Bhandari, S. K., and Saxena, S. N., 1986, Antibody response of guinea pigs to fluid and adsorbed tetanus toxoids, Indian J. Pathol. Microbiol. 29:285–292.

    PubMed  CAS  Google Scholar 

  • Al-Shakhshir, R., Regnier, F., White, J. L., and Hem, S. L., 1994, Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants, Vaccine 12:412–414.

    Article  Google Scholar 

  • Alving, C. R., Glass, M., and Detrick, B., 1992, Summary: Adjuvants/Clinical Trials Working Group, AIDS Res. Hum. Retroviruses 8:1427–1430.

    PubMed  CAS  Google Scholar 

  • Alving, C. R., Detrick, B., Richards, R. L., Lewis, M. G., Shafferman, A., and Eddy, G. A., 1993, Novel adjuvant strategies for experimental malaria and AIDS vaccines, Ann. N.Y. Acad. Sci. 690:265–275.

    Article  PubMed  CAS  Google Scholar 

  • Andre, F. E., Hepburn, A., and D’Hondt, E., 1990, Inactivated candidate vaccines for hepatitis A, Prog. Med. Virol. 37:72–95.

    PubMed  CAS  Google Scholar 

  • Aprile, M. A., and Wardlaw, A. C., 1966, Aluminum compounds as adjuvants for vaccine and toxoids in man: A review, Can. J. Public. Health 57:343–354.

    PubMed  CAS  Google Scholar 

  • Audibert, F. M., and Lise, L. D., 1993, Adjuvants: Current status, clinical perspectives and future prospects, Immunol. Today 14:281–284.

    Article  PubMed  CAS  Google Scholar 

  • Berman, P. W., Gregory, T., Crase, D., and Laski, L. A., 1985, Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D, Science 227:1490–1492.

    Article  PubMed  CAS  Google Scholar 

  • Blennow, M., Granstrom, M., and Bjorksten, B., 1990, Immunoglobulin E response to pertussis toxin after vaccination with acellular pertussis vaccine, in: Proceedings of the Sixth International Symposium on Pertussis (C. R. Manclark, ed.), Department of Health and Human Services, Bethesda, DHHS Publication No. (FDA) 90-1164, pp. 184–188.

    Google Scholar 

  • Blennow, M., Granstrom, M., and Strandell, A., 1994, Adverse reactions after diphtheria-tetanus booster in 10-year-old school children in relation to the type of vaccine given for the primary vaccination, Vaccine 12:427–430.

    Article  PubMed  CAS  Google Scholar 

  • Bomford, R., 1980a, The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund’s incomplete and complete adjuvants, Alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin, Clin. Exp. Immunol. 39:426–434.

    PubMed  CAS  Google Scholar 

  • Bomford, R., 1980b, The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund’s incomplete and complete adjuvants, Alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin, Clin. Exp. Immunol. 39:435–443.

    PubMed  CAS  Google Scholar 

  • Bomford, R., 1984, Relative adjuvant efficacy of A1(OH)3 and saponin is related to the immunogenicity of the antigen, Int. Arch. Allergy Appl. Immunol. 75:280–281.

    Article  PubMed  CAS  Google Scholar 

  • Bomford, R., 1989, Aluminium salts: Perspectives in their use as adjuvants, in: Immunological Adjuvants and Vaccines (G. Gregoriadis, A. C. Allison, and G. Poste, eds.), Plenum Press, New York, pp. 35–41.

    Chapter  Google Scholar 

  • Butler, N. R., Wilson, B. D. R., Benson, P. F., Dudgeon, J. A., Ungar, J., and Beale, A. J., 1962a, Response of infants to pertussis vaccine at one week and to poliomyelitis, diphtheria and tetanus vaccine at six months, Lancet 2:112–114.

    Article  PubMed  CAS  Google Scholar 

  • Butler, N. R., Wilson, B. D. R., Benson, P. F., Dudgeon, J. A., Ungar, J., and Beale, A. J., 1962b, Effect of aluminum phosphate on antibody response to killed poliomyelitis vaccine, Lancet 2:114–115.

    Article  PubMed  CAS  Google Scholar 

  • Cameron, J., 1976, Problems associated with control testing of pertussis vaccine, Adv. Appl. Microbiol. 20:57–80.

    Article  PubMed  CAS  Google Scholar 

  • Cameron, J., 1979, Pertussis vaccine: Control testing problems, in: International Symposium on Pertussis held at the National Institutes of Health, Bethesda, November 1–3, 1978 (C. R. Manclark and J. C. Hill, eds.), U.S. Government Printing Office, Washington, DC, pp. 200–207.

    Google Scholar 

  • Cameron, J., 1980, The potency of whooping cough (pertussis) vaccines in Canada, J. Biol. Stand. 8:297–302.

    Article  PubMed  CAS  Google Scholar 

  • Cameron, J., 1985, in: Discussion, Dev. Biol. Stand. 61:315.

    Google Scholar 

  • Cameron, J., and Knight, P. A., 1972, Interaction of components of triple antigen (diphtheria, tetanus, pertussis, DTP), in: Proceedings of the Symposium on Combined Vaccines, Yugoslavian Academy of Science and Arts, Zagreb, pp. 55–67.

    Google Scholar 

  • Claesson, B. A., Trollfors, B., Lagergard, T., Taranger, J., Bryla, D., Otterman, G., Crampton, T., Yang, Y., Reimer, C. B., Robbins, J. B., and Schneerson, R., 1988, Clinical and immunologic responses to the capsular Polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18-to 23-month-old children, J. Pediatr. 112:695–702.

    Article  PubMed  CAS  Google Scholar 

  • Clemmenson, O., and Knudsen, H. E., 1980, Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen, Contact Dermatitis 6:305–308.

    Article  Google Scholar 

  • Cogne, M., Ballet, J. J., Schmitt, C., and Bizzini, B., 1985, Total and IgE antibody levels following booster immunization with aluminium adsorbed and non adsorbed tetanus toxoid in humans, Ann. Allergy 54:148–151.

    PubMed  CAS  Google Scholar 

  • Collier, L. H., Polakoff, S., and Mortimer, J., 1979, Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines, Lancet 1:1364–1368.

    Article  PubMed  CAS  Google Scholar 

  • Cooper, P. D., 1994, The selective induction of different immune responses by vaccine adjuvants, in: Strategies in Vaccine Design (G. L. Ada, ed.), R. G. Landes Company, Austin, pp. 125–158.

    Google Scholar 

  • Cooper, P. D., McComb, C., and Steele, E. J., 1991, The adjuvanticity of algammulin, a new vaccine adjuvant, Vaccine 9:408–415.

    Article  PubMed  CAS  Google Scholar 

  • Coursaget, P., Yvonnet, B., Relyveld, E. H., Barres, J. L., Dubourg, J. C., Diouf, C., Diopo-Mar, I., and Chiron, J. P., 1985, Simultaneous administration of hepatitis B vaccine with diphtheria/tetanus/pertussis/polio vaccine, in: Proceedings of the Seventh International Conference on Tetanus (G. Nistico, P. Maestroni, and M. Pitzurra, eds.), Gangemi, Rome, pp. 401–406.

    Google Scholar 

  • Coursaget, P., Yvonnet, B., Relyveld, E. H., Barres, J. L., Diop-Mar, I., and Chiron, J. P., 1986, Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: Immune response to diphtheria toxoid, tetanus toxoid, pertussis and hepatitis B surface antigen, Infect. Immun. 51:784–787.

    PubMed  CAS  Google Scholar 

  • Cvjetanovic, B., and Umera, K., 1965, The present status of field and laboratory studies of typhoid and paratyphoid vaccines with special reference to studies sponsored by the World Health Organization, Bull. W.H.O. 32:29–36.

    PubMed  CAS  Google Scholar 

  • Davenport, F. M., Hennessy, A. V., and Askin, F. B., 1968, Lack of adjuvant effect of AIPO4 on purified influenza virus haemagglutinins in man, J. Immunol. 100:1139–1140.

    PubMed  CAS  Google Scholar 

  • Durand, C., Pineau, A., Bureau, B., and Stalder, J. F., 1992, Complications cutanees des vaccinations diphterie, tetanos, coqueluche, poliomyelite (tetracoq) role de l’hydroxyde d’alumine, Nouv. Dermatol. 11:523–526.

    Google Scholar 

  • Edelman, R., 1980, Vaccine adjuvants, Rev. Infect. Dis. 2:370–383.

    Article  PubMed  CAS  Google Scholar 

  • Einhorn, M. S., Weinberg, G. A., Anderson, E. L., Granoff, P. L., and Granoff, D. M., 1986, Immunogenicity in infants of Haemophilus influenzae type b Polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein, Lancet 2:299–302.

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., and Gilley, R. M., 1991, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun. 59:2978–2986.

    PubMed  CAS  Google Scholar 

  • Erodohazi, M., and Newman, R. L., 1971, Aluminium hydroxide granuloma, Br. Med. J. 3:621–623.

    Article  Google Scholar 

  • Flebbe, L. M., and Braley-Mullen, H., 1986, Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens, Cell. Immunol. 99:119–127.

    Article  PubMed  CAS  Google Scholar 

  • Food and Drug Administration, 1987, Summary Minutes — Allergenic Products Advisory Committee and Report on Safety Considerations for the Aluminum Component of Alum-precipitated Allergenic Extracts, Office of Biologics Research and Review, Biologics Information Staff (NFN-20) FDA, Bethesda.

    Google Scholar 

  • Frost, L., Johansen, P., Pedersen, S., Veien, N., Ostergaard, P. A., and Nielsen, M. H., 1985, Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts, Allergy 40:368–372.

    Article  PubMed  CAS  Google Scholar 

  • Fulthorpe, A. J., 1965, The influence of mineral carriers on the simultaneous active and passive immunization of guinea pigs against tetanus, J. Hyg. 63:243–262.

    Article  CAS  Google Scholar 

  • Gateff, C., Relyveld, E. H., Le Gonidec, G., Vincent, J., Labusquiere, R., McBean, M, Monchicourt, D., and Chambon, L., 1973, Etude d’une nouvelle association vaccinale quintuple, Ann. Microbiol. (Inst. Pasteur) 124B:387–409.

    Google Scholar 

  • Glenny, A.T., Pope, C. G., Waddington, H., and Wallace, U., 1926, The antigenic value of toxoid precipitated by potassium alum, J. Pathol. Bacteriol. 29:38–45.

    Google Scholar 

  • Glenny, A. T., Buttle, G. A. H., and Stevens, M. F., 1931, Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: Toxoid precipitated with alum, J. Pathol. Bacteriol. 34:267–275.

    Article  CAS  Google Scholar 

  • Grun, J. L., and Maurer, P. H., 1989, Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin-1 in proliferative responses, Cell. Immunol. 121:134–145.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, R. K., and Relyveld, E. H., 1991, Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine, Vaccine 9:699–702.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, R. K., and Siber, G. R., 1994, Comparison of adjuvant activities of aluminum phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid, Biologicals 22:53–63.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, R. K., Sharma, S. B., Ahuja, S., and Saxena, S. N., 1987, The effect of aluminum phosphate adjuvant on the potency of pertussis vaccine, J. Biol. Stand. 15:99–101.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, R. K., Saxena, S. N., Sharma, S. B., and Ahuja, S., 1990, Immunogenicity of glutaraldehyde inactivated pertussis vaccine, Vaccine 8:563–568.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, R. K., Saxena, S. N., Sharma, S. B., and Ahuja, S., 1992, Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives, Indian J. Med. Res. 95:8–11.

    PubMed  CAS  Google Scholar 

  • Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efraim, S., and Gupta, C. K., 1993, Adjuvants — A balance between toxicity and adjuvanticity, Vaccine 11:293–306.

    Article  PubMed  CAS  Google Scholar 

  • Haas, R., and Thomssen, R., 1961, Uber den entwicklungsstand der in der immunbiologie gebrauch-lichen adjuvantien, Ergeb. Mikrobiol. 34:27–119.

    CAS  Google Scholar 

  • Haas, R., Keller, W., and Kikuth, W., 1955, Grundsatzliches zur aktiven Schutzimpfung gegen poliomyelitis, Dtsch. Med. Wochenschr. 80:273.

    Article  PubMed  CAS  Google Scholar 

  • Harrison, W. T., 1935, Some observations on the use of alum-precipitated diphtheria toxoid, Am. J. Public Health 25:298–300.

    Article  CAS  Google Scholar 

  • Hedenskog, S., Bjorksten, B., Blennow, M., Granstrom, G., and Granstrom, M., 1989, Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine, Int. Arch. Allergy Appl. Immunol. 89:156–161.

    Article  PubMed  CAS  Google Scholar 

  • Hennessen, W., 1965, The mode of action of mineral adjuvants, Prog. Immunobiol. Stand. 2:71–79.

    Google Scholar 

  • Hennessen, W., 1967, Mode of action and consequences for standardization of adjuvanted vaccines, Symp. Ser. Immunobiol. Stand. 6:319–326.

    Google Scholar 

  • Hilton, M. L., and Wurland, W. L., 1970, Pertussis containing vaccines: The relationship between laboratory toxicity tests and reactions in children, Symp. Ser. Immunobiol. Stand. 13:150–156.

    Google Scholar 

  • Holt, L. B., 1950, Developments in Diphtheria Prophylaxis, Heinemann Medical Books, London, pp. 1–181.

    Google Scholar 

  • Holt, L. B., 1955, Quantitative studies in diphtheria prophylaxis: An attempt to derive a mathematical characterization of the antigenicity of diphtheria prophylactic, Biometric 11:83–94.

    Article  Google Scholar 

  • Ickovic, M. R., Relyveld, E. H., Henocq, E., David, B., and Marie, F. N., 1983, Calcium phosphate adjuvanted allergens: Total and specific IgE levels before and after immunotherapy with house dust and Dermatophagoides pteronyssinus extracts, Ann. Immunol. (Institut Pasteur) 134D:385–398.

    Article  CAS  Google Scholar 

  • Ipsen, J., Jr., 1954, Immunization of adults against diphtheria and tetanus, N. Engl. J. Med. 251:459–466.

    Article  PubMed  Google Scholar 

  • Jensen, O. M., and Koch, C., 1988, On the effect of A1(OH)3 as an immunological adjuvant, Acta Pathol. Microbiol. Immunol. Scand. 96:257–264.

    CAS  Google Scholar 

  • Jones, F. G., and Moss, J. M., 1936, Studies on tetanus toxoid. I. The antitoxic titer of human subjects following immunization with tetanus toxoid and tetanus alum precipitated toxoid, J. Immunol. 30:115–125.

    Google Scholar 

  • Kensil, C. R., Barrett, C., Kushner, N., Beltz, G., Storey, J., Patel, U., Recchia, J., Aubert, A., and Marciani, D., 1991, Development of a genetically engineered vaccine against feline leukemia virus infection, J. Am. Vet. Med. Assoc. 199:1423–1427.

    PubMed  CAS  Google Scholar 

  • Krantz, I., Sekura, R., Trollfors, B., Taranger, J., Zackrisson, G., Lagergard, T., Schneerson, R., and Robbins, J., 1990, Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18-to 23-month-old children, J. Pediatr. 116:539–543.

    Article  PubMed  CAS  Google Scholar 

  • Kuwert, E. K., Menzel, H., Marcus, I., and Majer, M., 1978, Antigenicity of low concentrated HDCS vaccine with and without adjuvant as compared to the standard fluid formulation, Dev. Biol Stand. 40:29–34.

    PubMed  CAS  Google Scholar 

  • Levine, L., 1972, A predictive equation for the primary immune response of mice to adsorbed tetanus toxoid as a function of dose of antigen and dose of adjuvant, J. Immunol. 109:1138–1142.

    CAS  Google Scholar 

  • Levine, L., Stone, J. L., and Wyman, L., 1955, Factors affecting the efficiency of the aluminum adjuvant in diphtheria and tetanus toxoids, J. Immunol. 75:301–307.

    PubMed  CAS  Google Scholar 

  • Levine, L., Ipsen, J., and McComb, J. A., 1961, Adult immunization: Preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use, Am. J. Hyg. 73:20–35.

    PubMed  CAS  Google Scholar 

  • Levine, L., McComb, J. A., Dwyer, R. C., and Latham, W. C., 1966, Active-passive tetanus immunization, N. Engl. J. Med. 274:186–190.

    Article  PubMed  CAS  Google Scholar 

  • Lindblad, E. B., and Sparck, J. V., 1987, Basic concepts in the application of immunological adjuvants, Scand. J. Lab. Anim. Sci. 14:1–13.

    Google Scholar 

  • MacLennan, R., Levine, L., Newell, K. W., and Edsall, G., 1973, The early primary immune response to adsorbed tetanus toxoid in man, Bull. W.H.O. 49:615–626.

    PubMed  CAS  Google Scholar 

  • Mannhalter, J. W., Neychev, H. O., Zlabinger, G. J., Ahmad, R., and Eibl, M. M., 1985, Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: Effect of antigen uptake and antigen presentation, Clin. Exp. Immunol. 61:143–151.

    PubMed  CAS  Google Scholar 

  • Mark, A., and Granstrom, M., 1994, The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine, Acta Paediatr. 83:159–163.

    Article  PubMed  CAS  Google Scholar 

  • Mark, A., Bjorksten, B., and Granstrom, M., 1995, Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines, Vaccine (in press).

    Google Scholar 

  • Matsuhasi, T., and Ikegami, H., 1982, Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine, J. Infect. Dis. 146:290.

    Article  Google Scholar 

  • May, J. C., Progar, J. J., and Chin, R., 1984, The aluminum content of biological products containing aluminum adjuvants: Determination by atomic absorption spectrometry, J. Biol. Stand. 12:175–183.

    Article  PubMed  CAS  Google Scholar 

  • Menon, P. S., Sahai, G., Joshi, V. B., Murthy, R. G. S., Boprai, M. S., and Thomas, A. K., 1976, Field trial on frozen and thawed tetanus toxoid, Indian J. Med. Res. 64:25–32.

    PubMed  CAS  Google Scholar 

  • Munder, P. G., Ferber, E., Modolell, M., and Fischer, H., 1969, The influence of various adjuvants on the metabolism of phospholipids in macrophages, Int. Arch. Allergy 36:117–128.

    Article  PubMed  CAS  Google Scholar 

  • Murray, K., Bruce, S. A., Hinnen, A., Wingfield, P., van Erd, P. M. C. A., de Reus, A., and Schellekens, H., 1984, Hepatitis B virus antigens made in microbial cells immunize against viral infection, EMBO J. 3:645–650.

    PubMed  CAS  Google Scholar 

  • Nagel, J., Svec, D., Water, T., and Fireman, P., 1977, IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (TD) toxoids, J. Immunol. 118:334–341.

    PubMed  CAS  Google Scholar 

  • Nicklas, W., 1992, Aluminum salts, Res. Immunol. 143:489–494.

    Article  PubMed  CAS  Google Scholar 

  • Nixon, A., Zaghouani, H., Penney, C. L., Lacroix, M., Dionne, G., Anderson, S. A., Kennedy, R. C., and Bona, C. A., 1992, Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503–535 from HIV gp160, Viral Immunol. 5:141–150.

    Article  PubMed  CAS  Google Scholar 

  • Novotny, P., and Brookes, J. E., 1975, The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test, J. Biol. Stand. 3:11–29.

    Article  PubMed  CAS  Google Scholar 

  • Odelram, H., Granstrom, M., Hedenskog, S., Duchen, K., and Bjorksten, B., 1994, Immunoglobulin E and G responses to pertussis toxin after booster immunization in atopy, local reactions and aluminium content of the vaccines, Pediatr. Allergy Immunol. 5:118–123.

    Article  PubMed  CAS  Google Scholar 

  • Peetermans, J., 1992, Production, quality control and characterization of an inactivated hepatitis A vaccine, Vaccine 10(Suppl. 1):S99–S101.

    Article  PubMed  Google Scholar 

  • Pittman, M., 1954, Variability of the potency of pertussis vaccine in relation to the number of bacteria, J. Pediatr. 45:57–69.

    Article  PubMed  CAS  Google Scholar 

  • Podda, A., Nencioni, L., Marsili, I., Peppoloni, S., Volpini, G., Donati, D., Di Tommaso, A., De Magistris, M. T., and Rappuoli, R., 1991, Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 KDa, Vaccine 9:741–745.

    Article  PubMed  CAS  Google Scholar 

  • Preston, N. W., 1976, Protection by pertussis vaccine: Little cause for concern, Lancet 1:1065–1067.

    Article  PubMed  CAS  Google Scholar 

  • Preston, N. W., 1979, Some unsolved problems with vaccines, Prog. Drug Res. 23:9–26.

    PubMed  CAS  Google Scholar 

  • Preston, N. W., Mackay, R. I., Bomford, F. N., Crofts, J. E., and Burland, WL., 1974, Pertussis agglutinins in vaccinated children: Better response with adjuvant, J. Hyg. 73:119–125.

    Article  CAS  Google Scholar 

  • Prigge, R., 1942, Wirksamkeit und schutzkraft der diphtherie-impfstoffe, Behringwerk Mitt. 21:75–99.

    Google Scholar 

  • Prigge, R., 1949, Die beziehung zwischen dem antigengehalt der diphtherie-impfstoffe und ihrer Wirksamkeit, Klin. Wochenschr. 27:685–690.

    Article  Google Scholar 

  • Ramanathan, V. D., Badenoch-Jones, P., and Turk, J. L., 1979, Complement activation by aluminium and zirconium compounds, Immunology 37:881–888.

    PubMed  CAS  Google Scholar 

  • Relyveld, E. H., 1980, Current developments in production and testing of tetanus and diphtheria vaccines, in: New Developments with Human and Veterinary Vaccines (A. Mizrahi, I. Hertman, M. Klingberg, and A. Kohn, eds.), Liss, New York, pp. 51–76.

    Google Scholar 

  • Relyveld, E. H., 1985, Immunological, prophylactic and standardization aspects in tetanus, in: Proceedings of the Seventh International Conference on Tetanus (G. Nistico, P. Maestroni, and M. Pitzurra, eds.), Gangemi, Rome, pp. 215–227.

    Google Scholar 

  • Relyveld, E. H., 1986, Preparation and use of calcium phosphate adsorbed vaccines, Dev. Biol. Stand. 65:131–136.

    PubMed  CAS  Google Scholar 

  • Relyveld, E., and Chermann, J. C., 1994, Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen, Biomed. Pharmacother. 48:79–83.

    Article  PubMed  CAS  Google Scholar 

  • Relyveld, E. H., and Raynaud, M., 1967, Etudes sur le phosphate de calcium comme adjuvant de l’immunite, Symp. Ser. Immunobiol. Stand. 6:77–88.

    Google Scholar 

  • Relyveld, E. H., Hencoq, E., and Raynaud, M., 1964, Etude de la vaccination antidiphterique de sujets alergiques avec une anatoxine pure adsorbee sur phosphate de calcium, Bull W.H.O. 30:321–325.

    PubMed  CAS  Google Scholar 

  • Relyveld, E. H., Martin, R., Raynaud, M., Damas, J.-P., Therond, C., Henocq, E., Romain, F., Turpin, A., Ceolin, G., Cheve, J., Digeon, M., and Cheyroux, M., 1969, Le phosphate de calcium comme adjuvant dans les vaccinations chez l’homme, Ann. Institut Pasteur 116:300–326.

    CAS  Google Scholar 

  • Relyveld, E. H., Gateff, C., Chambon, L., Guerin, N., and, Charpin, M., 1973, Etudes sur le vaccinations en Afrique, Symp. Series Immunobiol. Stand. 22:215–222.

    Google Scholar 

  • Relyveld, E. H., Lavergne, M., and De Rudder, J., 1974, Taux d’immunoglobulines (IgG; IgA; IgM et IgE) apres stimulation antigenique ches des sujets europeens et africains, Dev. Biol. Stand. 27:79–90.

    PubMed  CAS  Google Scholar 

  • Relyveld, E. H., Ickovic, M. R., Henocq, E., and Garcelon, M., 1985, Calcium phosphate adjuvanted allergens, Ann. Allergy 54:521–529.

    PubMed  CAS  Google Scholar 

  • Relyveld, E., Bengounia, A., Huet, M., and Kreeftenberg, J. G., 1991, Antibody response of pregnant women to two different adsorbed tetanus toxoids, Vaccine 9:369–372.

    Article  PubMed  CAS  Google Scholar 

  • Rethy, L., Solyom, F., Bacskai, L., Geresi, M., Gerhardt, Z., Koves, B., Kriston, K., Magyar, T., Masek, I., Nagy, B., and Nemesi, M., 1985, Design and control of new type vaccines. Efficacy testing of adsorbed and freeze-dried toxoid-virus-bacterium combined vaccines, Ann. Immunol. Hung. 25:49–57.

    Google Scholar 

  • Saroso, J. S., Bahrawi, W., Witjaksono, H., Budiarso, R. L. P., Brotowasisto, B. Z., Dewitt, W. E., and Gomez, C. Z., 1978, A controlled field trial of plain and aluminum hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973–75, Bull. W.H.O. 56:619–627.

    PubMed  CAS  Google Scholar 

  • Sato, Y., Kimura, M., and Fukumi, H., 1984, Development of a pertussis component vaccine in Japan, Lancet 1:122–126.

    Article  PubMed  CAS  Google Scholar 

  • Schmidt, G., 1967, The adjuvant effect of aluminum hydroxide in influenza vaccine, Symp. Ser. Immunobiol. Stand. 6:275–282.

    Google Scholar 

  • Seal, S. C., and Johnson, S. J., 1941, Studies on the purification of alum-precipitated diphtheria toxoid, J. Infect. Dis. 69:102–107.

    Article  CAS  Google Scholar 

  • Siber, G. R., Thakrar, N., Yancey, B. A., Herzog, L., Todd, C., Cohen, N., Sekura, R. D., and Lowe, C. U., 1991, Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children, Vaccine 9:735–740.

    Article  PubMed  CAS  Google Scholar 

  • Stewart-Tull, D. E. S., 1989, Recommendations for the assessment of adjuvants (immunopotentiators), in: Immunological Adjuvants and Vaccines (G. Greogoriadis, A. C. Allison, and G. Poste, eds.), Plenum Press, New York, pp. 213–226.

    Chapter  Google Scholar 

  • Suri, J. C., and Rubbo, S. D., 1961, Immunization against tetanus, J. Hyg. 59:29–48.

    Article  CAS  Google Scholar 

  • United States Minimum Requirements, 1956, Tetanus and Diphtheria Toxoids Combined Precipitated, Adsorbed (For Adult Use), Amendment No. 1, U.S. Department of Health, Education & Welfare, National Institutes of Health, Bethesda.

    Google Scholar 

  • van Ramshorst, J. D., 1949, The adsorption of diphtheria toxoid on aluminum phosphate, Recl. Trav. Chim. Pays-Bas 68:169–180.

    Article  Google Scholar 

  • Vassilev, T. L., 1978, Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea-pigs to tetanus toxoid, Allergy 33:155–159.

    Article  PubMed  CAS  Google Scholar 

  • Volk, V. K., and Bunney, W. E., 1939, Diphtheria immunization with fluid toxoid and alum precipitated toxoid. Preliminary report, Am. J. Public Health 29:197–204.

    Article  CAS  Google Scholar 

  • Volk, V. K., and Bunney, W. E., 1942, Diphtheria immunization with fluid toxoid and alum precipitated toxoid, Am. J. Public Health 32:690–699.

    Article  CAS  Google Scholar 

  • Walls, R. S., 1977, Eosinophil response to alum adjuvants: Involvement of Tcells in non-antigen-dependent mechanisms, Proc. Soc. Exp. Biol. Med. 156:431–435.

    PubMed  CAS  Google Scholar 

  • Warren, H. S., Vogel, F. R., and Chedid, L. A., 1986, Current status of immunological adjuvants, Annu. Rev. Immunol. 4:369–388.

    Article  PubMed  CAS  Google Scholar 

  • White, J. L., and Schlageter, E. A., 1934, Diphtheria toxoid. Comparative immunizing value with and without alum, as indicated by Schick test, J. Am. Med. Assoc. 102:915.

    Article  Google Scholar 

  • White, R. G., 1967, Concepts relating to the mode of action of adjuvants, Symp. Ser. Immunobiol. Stand. 6:3–12.

    Google Scholar 

  • White, R. G., Coons, A.H., and Connolly, J. M., 1955, Studies on antibody production. III. The alum granuloma, J. Exp. Med. 102:73–82.

    Article  PubMed  CAS  Google Scholar 

  • Woodard, L. F., 1989, Adjuvant activity of water-insoluble surfactants, Lab. Anim. Sci. 39:222–225.

    PubMed  CAS  Google Scholar 

  • World Health Organization, 1976, Immunological adjuvants, in: Tech. Rep. Series 595, World Health Organization, Geneva, pp. 3–40.

    Google Scholar 

  • World Health Organization, 1977, Manual for the Production and Control of Vaccines — Tetanus Toxoid, BLG/UNDP/77.2 Rev. 1.

    Google Scholar 

  • World Health Organization, 1990, Requirements for diphtheria, tetanus, pertussis and combined vaccines, in: Technical Report Series 800, World Health Organization, Geneva, pp. 87–179.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts Public Health Biologic Laboratories, State Laboratory Institute, Boston, Massachusetts, 02130, USA

    Rajesh K. Gupta, Bradford E. Rost & George R. Siber

  2. Office d’Etudes en Vaccinologie, Paris, France

    Edgar Relyveld

Authors
  1. Rajesh K. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradford E. Rost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edgar Relyveld
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George R. Siber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Genentech, Inc., South San Francisco, California, USA

    Michael F. Powell

  2. Vaxcel, Inc., Norcross, Georgia, USA

    Mark J. Newman

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gupta, R.K., Rost, B.E., Relyveld, E., Siber, G.R. (1995). Adjuvant Properties of Aluminum and Calcium Compounds. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1823-5_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5737-7

  • Online ISBN: 978-1-4615-1823-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation